Frank Bohnenstengel

Publications

1.5K

Citations

H-Index

1993

Active since

Affiliations

Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology(Current)

Robert Bosch (Germany)

Technische Universität Braunschweig

Universität Greifswald

Heinrich Heine University Düsseldorf

Frank Bohnenstengel is an author at Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology specializing in pharmacology, medicine, and biochemistry.

Top concepts

PharmacologyMedicineBiochemistryDrug AnalysisMetabolismDrug DiscoveryNatural SciencesHuman MetabolismToxicologyBioanalysis

Publications per year

1993–2002

Publications

Human CYP2B6: expression, inducibility and catalytic activities.

Laurence Gervot, Bertrand Rochat, Jean‐Charles Gautier et al. · PubMed · 1999 · 245 citations

Escherichia Coli, Toxicological Mechanism, Protein Expression +17

Human CYP2B6

Laurence Gervot, Bertrand Rochat, Jean‐Charles Gautier et al. · Pharmacogenetics · 1999 · 214 citations

Cellular Enzymology, Biochemistry, Natural Sciences +11

Cyclophosphamide pharmacokinetics and dose requirements in patients with renal insufficiency

Marion Haubitz, Frank Bohnenstengel, R. Brunkhorst et al. · Kidney International · 2002 · 175 citations · Full text

Dose Requirements, Hemodialysis, Renal Function +6

Chemistry and Biological Activity of Rocaglamide Derivatives and Related Compounds in Aglaia Species (Meliaceae)

Peter Proksch, RuAngelie Edrada‐Ebel, Rainer Ebel et al. · Current Organic Chemistry · 2001 · 136 citations

Biological Activity, Rocaglamide Derivatives, Medicinal Chemistry +14

Dose escalation of cyclophosphamide in patients with breast cancer: consequences for pharmacokinetics and metabolism.

Dagmar Busse, F.W. Busch, Frank Bohnenstengel et al. · Journal of Clinical Oncology · 1997 · 108 citations

Rows per page

1–5 of 21